In-line with the street expectation the Reserve Bank of India has left key policy rate unchanged but has lowered SLR by 25 bps. The apex bank has maintained its stance of calibrated tightening at the end of the fifth bi-monthly review that ended on Wednesday. 

Focusing on protecting investor interest, SEBI has published a note for investors stating the do’s and don’t one should follow while dealing with investment advisers. Read on to find out more.

The USFDA completed inspection of pharma major, Lupin’s units at Mandideep location and issued multiple observations over three units located there. Shares of Lupin have thus plunged intraday on Wednesday.

There are a number of ways in which you measure your investment rate of return. Read on to find the two most used rate of returns and when to use them.

The construction arm of Larsen&Toubro has won orders across two of its business segment, viz. Water and Effluent Treatment Business and L&T GeoStructure.

Etihad Airways is contemplating lending support to the debt-laden Jet Airways. Consequently, it engaged in discussions with some of the airline’s bankers about matters concerning cash flow and future business plans.

Alembic Pharmaceuticals Limited, a R&D focused pharma company, informed that the USFDA has given approval for its Candesartan Cilexetil Tablets USP 4 mg, 8 mg, and 16 mg. 

There are many ways to assess the riskiness of an investment. Read on to find how drawdown and its cousins can be used to get the right picture of investment risk.

All eyes will be on the monetary policy outcome wherein the RBI is expected to maintain the status quo on interest rates.